01—Abstract
Summary
Summary of the 10-Q/A filed October 16, 2012. Cited figures are marked; the original filing is the authoritative source.
Quture International, Inc. (BRRN) filed an amendment to its quarterly report for the period ending July 31, 2012.
The company, a smaller reporting entity, continues to face significant financial challenges, characterized by a substantial operating loss and a working capital deficit. Revenue remains minimal, with a slight decrease compared to the prior year's period. Operating expenses have significantly increased, primarily driven by software development costs and salaries/management fees.
Despite these challenges, Quture is actively working on developing and demonstrating its healthcare software products, QualOptima and QSurg, in partnership with InterSystems Corporation. The company is pursuing a go-to-market strategy focused on reference hospital installations and collaborations with healthcare law and accounting firms.
However, the company's ability to continue as a going concern is dependent on its success in securing additional financing through equity or debt, with significant dilution to existing shareholders being a likely outcome. Without successful fundraising, the company may be forced to cease operations, leading to a total loss for investors.
02—Key points
Key Highlights
- Significant increase in operating expenses, up from $108,106 to $357,640 year-over-year for the three-month period, primarily due to software development and salaries.
- Minimal and declining revenue, with $9,000 for the current period compared to $10,800 in the prior year.
- Substantial net loss of $553,485 for the three months ended July 31, 2012, compared to $98,418 in the prior year.
- The company's ability to continue as a going concern is in substantial doubt due to significant operating losses and a working capital deficit.
- Dependence on future equity or debt financing, with a high risk of dilution for existing shareholders and potential cessation of operations if financing is unsuccessful.
- Ongoing development and demonstration of healthcare software products (QualOptima and QSurg) through strategic partnerships, with a phased go-to-market strategy.
- Disclosure of material weaknesses in internal controls over financial reporting that have not been remediated due to limited resources.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-Q/AQ3 FY2012filed October 16, 2012Financial Statements
Q3 FY2012 against Q3 FY2011
| Line item | Q3 FY2012Q3 FY2011 | Change |
|---|---|---|
| Revenue | $9K$11K | −16.7% |
| R&D Expenses | $162K$51K | +220.4% |
| Operating Income | -$349K-$156K | −123.1% |
| Interest Expense | -$82K-$1K | −7272.8% |
| Net Income | -$553K-$315K | −76.0% |
05—Questions
Frequently Asked Questions
What is the company's current financial health and outlook?
Quture International, Inc. is facing severe financial difficulties. The company incurred a substantial net loss of $553,485 for the three months ended July 31, 2012, and its revenue remains minimal and declining. Operating expenses have significantly increased. The company's auditor has expressed substantial doubt about its ability to continue as a going concern, and its operations are heavily dependent on securing additional financing through equity or debt, which carries a high risk of dilution or potential cessation of operations if unsuccessful.
What are the primary drivers behind the increased operating expenses?
The significant increase in operating expenses, from $108,106 in the prior year's period to $357,640 for the three months ended July 31, 2012, is primarily driven by a substantial rise in software development costs (from $50,659 to $162,314) and increased salaries and management fees (from $30,000 to $90,486).
What is the company's strategy for future growth and revenue generation?
Quture International is focused on developing and marketing its healthcare software products, QualOptima and QSurg, in collaboration with InterSystems Corporation. The company is engaging in clinical trials and demonstrations at various medical institutions and plans a phased go-to-market strategy that includes partnerships with healthcare law and accounting firms to target major hospital corporations and healthcare systems.
What are the risks associated with investing in Quture International at this time?
The primary risks include the company's precarious financial situation, the substantial doubt regarding its ability to continue as a going concern, the significant increase in losses and expenses, and the potential for further dilution of existing shareholders' equity through necessary future financing. Failure to secure adequate funding could lead to the cessation of business operations, resulting in a total loss for investors. Additionally, the company has disclosed material weaknesses in its internal controls over financial reporting that remain unaddressed.
06—Continue